Drawing for MIRVEL

USPTO serial 79433446

MIRVEL

Reviewed by CopyMark Law Group

Reg. 8481121Status 700Registered
Filing date
Status date
Registration date
Oct 6, 2026
Examiner
MEBANE, ANASTASIA XAVIERA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MIRVEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

Michael J. Leonard Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical substances for biotechnological purposes, in particular for molecular biological use for the treatment of RNA (ribonucleic acid), as well as for reagent kits for industrial and scientific purposes, in particular for RNA treatment, not for medical or veterinary use; chemical substances for laboratory analysis and for use in kits, not for medical or veterinary use; diagnostic reagents for in vitro applications in clinical chemistry, except for medical or veterinary use; enzymes, other than for medical and veterinary purposes, for scientific purposes in particular for use in kits and for use in carrying out DNA labelling, DNA amplification, DNA analysis or RNA labelling, RNA amplification, RNA analysis and for enzyme preparationsACTIVE—
009Laboratory instruments, other than for medical purposes, namely automated micro- and macrofluidic instruments for the isolation, preparation, labelling, replication or screening of genetic material or RNA.ACTIVE—
042Scientific and technological services, in particular scientific research, development, diagnostics and analysis in the field of molecular biological use for the treatment of RNA (ribonucleic acid); scientific and technological services, in particular scientific research, development, diagnostics and analysis in the field of diagnostic chemicals and reagents; scientific and technological services for RNA separation, RNA purification, RNA isolation, RNA labeling, RNA amplification; scientific and technological services, namely scientific analysis in the field of research, development and diagnostics relating to genomics, transcriptomics, proteomics and genetic engineering.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 21, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 21, 2026RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2025DOCKASSIGNED TO EXAMINER—
Sep 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 28, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance